Live
Endpoints NewsExclusive: Genentech closes infectious disease unit in wave of research layoffs10x Genomics Blog10x Genomics Acquires Proteintech Genomics To Expand Proteomics Capabilities - Pulse 2.0IlluminaIllumina upgraded to overweight at JPMorgan on clinical demand outlook - Investing.comEndpoints NewsRare disease biotech Beren adds $300M from new financingsClinical OMICsAI Tool Classifies 102 CNS Tumor Subtypes in MinutesClinical OMICsFast-Acting Malaria Drug Shows Promise in First-in-Human StudyClinical OMICsUltrasensitive HPV DNA Blood Test Could Help Personalize Head and Neck Cancer TreatmentClinical OMICsDigital Portal Strengthens Patient Engagement in Cancer Clinical TrialsClinical OMICsAI Detects Breast Cancer Much Earlier than Radiologists AloneFierceBiotechFrom executive assistant to chief executive: Charles River CEO Birgit Girshick on ‘the next big transition’ in the CRO industryEndpoints NewsParabilis CEO Mathai Mammen on biotech's record IPOIlluminaCalls of the day: Illumina, Netflix and REITs - MSN
Thermo Fisher 26 avr. 2026

Is Thermo Fisher Scientific (TMO) Offering Value After Recent Share Price Weakness - simplywall.st

Is Thermo Fisher Scientific (TMO) Offering Value After Recent Share Price Weakness - simplywall.st

Original
Contenu indisponible. Consultez la source originale.